Hunan Fangsheng Pharm Co Ltd (603998) - Total Liabilities
Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has total liabilities worth CN¥1.22 Billion CNY (≈ $178.54 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hunan Fangsheng Pharm Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Hunan Fangsheng Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 603998 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Hunan Fangsheng Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Getein Biotech Inc
SHG:603387
|
China | CN¥765.68 Million |
|
Korea Investment Holdings Co Ltd
KO:071055
|
Korea | ₩124.06 Trillion |
|
CorMedix Inc
NASDAQ:CRMD
|
USA | $420.83 Million |
|
Carriage Services Inc
NYSE:CSV
|
USA | $1.10 Billion |
|
Jiangxi Chen Guang New Materials Co Ltd
SHG:605399
|
China | CN¥1.14 Billion |
|
Caribbean Utilities Company Ltd
TO:CUP-U
|
Canada | $473.04 Million |
|
Zhengzhou Qianweiyangchu Food Co Ltd
SHE:001215
|
China | CN¥564.16 Million |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
USA | $16.63 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Hunan Fangsheng Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Hunan Fangsheng Pharm Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Fangsheng Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Fangsheng Pharm Co Ltd (2011–2025)
The table below shows the annual total liabilities of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $183.35 Million |
-18.20% |
| 2024-12-31 | CN¥1.53 Billion ≈ $224.14 Million |
+2.64% |
| 2023-12-31 | CN¥1.49 Billion ≈ $218.36 Million |
+5.52% |
| 2022-12-31 | CN¥1.41 Billion ≈ $206.94 Million |
+0.95% |
| 2021-12-31 | CN¥1.40 Billion ≈ $204.99 Million |
+43.37% |
| 2020-12-31 | CN¥977.05 Million ≈ $142.97 Million |
+23.29% |
| 2019-12-31 | CN¥792.51 Million ≈ $115.97 Million |
+49.58% |
| 2018-12-31 | CN¥529.81 Million ≈ $77.53 Million |
+57.97% |
| 2017-12-31 | CN¥335.39 Million ≈ $49.08 Million |
+15.13% |
| 2016-12-31 | CN¥291.31 Million ≈ $42.63 Million |
+115.88% |
| 2015-12-31 | CN¥134.94 Million ≈ $19.75 Million |
+56.03% |
| 2014-12-31 | CN¥86.48 Million ≈ $12.66 Million |
+8.79% |
| 2013-12-31 | CN¥79.50 Million ≈ $11.63 Million |
+39.51% |
| 2012-12-31 | CN¥56.98 Million ≈ $8.34 Million |
-17.28% |
| 2011-12-31 | CN¥68.89 Million ≈ $10.08 Million |
-- |
About Hunan Fangsheng Pharm Co Ltd
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infe… Read more